Dishman Carbogen Amcis

259.05
-6.95
(-2.61%)
Market Cap
4,170.40 Cr
EPS
0.21
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
307.98
52 Week Low
155.05
PB Ratio
0.69
Debt to Equity
0.40
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,672.50
#1 4,03,064.30
35.03
#1 54,729.00
12.06
#1 10,980
-18.99
48.33
6,938.00
1,82,868.00
83.99
9,360.00
0.89
2,117
23.05
68.54
1,488.30
1,22,004.30
23.36
28,409.50
7.12
5,291
30.28
54.26
3,322.40
1,13,457.10
58.72
11,539.40
11.59
1,911
10.91
62.08
1,283.80
1,09,370.50
19.31
33,741.20
12.36
5,725
21.14
54.13
983.20
1,00,502.70
21.18
22,573.80
13.82
3,977
-0.19
69.99
2,431.70
99,484.10
50.50
12,207.40
19.57
1,925
-10.91
59.65
1,922.10
90,361.80
26.75
22,192.10
#1 19.94
3,024
#1 112.49
53.08
34,160.00
73,278.20
51.39
6,409.15
10.80
1,417
27.83
64.97
1,147.70
68,830.80
#1 19.29
31,378.10
17.55
3,366
-0.50
63.70

Automatic Screeners on ScanX

Forecast
Actual
Growth Rate
Revenue Growth
8.33 %
Net Income Growth
415.10 %
Cash Flow Change
44.37 %
ROE
435.29 %
ROCE
-107.32 %
EBITDA Margin (Avg.)
-19.32 %

Quarterly Financial Results

Quarterly Financials
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
419
368
440
372
491
345
440
446
468
455
447
441
631
509
456
528
533
483
454
478
535
561
469
581
573
546
623
646
625
730
595
657
662
525
796
690
724
Expenses
318
271
321
263
388
270
311
339
330
362
319
346
480
403
322
417
405
431
359
406
463
450
362
453
559
452
535
529
613
602
529
610
595
500
645
542
575
EBITDA
101
97
118
109
103
75
129
107
138
93
128
95
151
107
135
111
128
52
95
72
72
111
106
129
14
94
88
118
13
128
66
47
67
25
151
148
149
Operating Profit %
22 %
25 %
25 %
26 %
20 %
20 %
28 %
21 %
27 %
19 %
26 %
19 %
21 %
20 %
29 %
20 %
21 %
9 %
18 %
13 %
12 %
18 %
21 %
19 %
2 %
16 %
13 %
17 %
1 %
17 %
10 %
6 %
9 %
4 %
18 %
21 %
20 %
Depreciation
30
51
55
51
57
51
55
55
51
54
58
58
71
67
70
72
74
74
78
79
77
75
74
75
84
75
80
50
76
70
75
80
85
71
72
72
79
Interest
21
23
20
13
10
11
13
13
11
15
15
14
13
14
17
11
20
12
13
14
9
12
14
15
16
19
20
22
24
29
28
33
31
32
37
49
42
Profit Before Tax
67
36
51
50
83
14
74
68
75
58
71
75
106
46
65
51
35
-34
4
-22
-14
24
19
39
-85
-0
-12
46
-88
30
-36
-66
-49
-78
42
27
28
Tax
17
6
13
17
40
1
26
26
24
18
27
23
30
12
24
18
-15
-12
-3
-6
121
8
7
3
-41
-4
-2
-1
-17
13
5
-7
21
0
9
22
-15
Net Profit
50
30
38
33
43
13
48
42
51
40
44
51
76
34
41
33
50
-21
7
-16
-135
16
11
35
-45
4
-10
47
-71
17
-41
-60
-70
-78
33
5
43
EPS in ₹
6.17
1.88
2.37
2.01
2.65
0.81
3.00
2.60
3.17
2.46
2.73
3.18
4.70
2.13
2.55
2.04
3.11
-1.37
0.47
-1.02
-8.61
1.02
0.71
2.26
-2.85
0.26
-0.64
3.00
-4.51
1.08
-2.61
-3.80
-4.46
-4.95
2.11
0.30
2.75

Balance Sheet

Balance Sheet
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
6,593
7,177
7,329
8,200
8,366
8,638
9,454
9,581
9,999
Fixed Assets
4,852
5,066
5,098
5,678
5,698
5,773
6,188
6,724
3,471
Current Assets
1,245
1,546
1,554
1,779
1,704
1,839
1,918
1,928
2,197
Capital Work in Progress
133
151
175
234
486
780
1,043
646
255
Investments
40
196
167
191
172
324
249
102
900
Other Assets
1,569
1,764
1,889
2,097
2,010
1,761
1,973
2,109
0
Total Liabilities
6,593
7,177
7,329
8,200
8,366
8,638
9,454
9,581
9,999
Current Liabilities
994
1,178
1,198
1,569
1,290
1,420
1,798
2,555
1,925
Non Current Liabilities
786
891
751
916
1,377
1,669
1,845
1,399
2,243
Total Equity
4,814
5,107
5,379
5,715
5,699
5,549
5,810
5,628
5,832
Reserve & Surplus
4,814
5,075
5,347
5,684
5,668
5,518
5,778
5,596
5,800
Share Capital
0
32
32
31
31
31
31
31
31

Cash Flow

Cash Flow
2011
2012
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-3
-19
59
7
11
46
122
-133
22
132
Investing Activities
-231
-104
-107
-297
-169
-442
-380
-619
-494
-230
Operating Activities
203
154
303
226
282
585
513
355
266
384
Financing Activities
26
-68
-137
78
-102
-98
-11
130
250
-22

Share Holding

% Holding
Apr 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
63.17 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
8.80 %
8.61 %
8.70 %
8.04 %
8.17 %
8.74 %
9.49 %
DIIs
12.80 %
8.85 %
6.66 %
6.05 %
6.18 %
6.75 %
6.54 %
4.28 %
3.87 %
2.56 %
3.14 %
3.52 %
3.69 %
2.37 %
1.48 %
1.23 %
1.42 %
1.26 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
10.93 %
21.60 %
22.62 %
24.75 %
24.20 %
23.55 %
23.73 %
25.85 %
25.66 %
24.61 %
24.57 %
24.64 %
24.54 %
25.17 %
27.10 %
27.43 %
26.22 %
25.31 %
Others
13.09 %
10.24 %
11.40 %
9.87 %
10.30 %
10.37 %
10.42 %
10.55 %
11.15 %
13.50 %
12.97 %
3.72 %
3.85 %
4.45 %
4.06 %
3.85 %
4.29 %
4.62 %
No of Share Holders
43,186
58,738
54,077
60,726
54,662
56,322
56,986
59,654
61,175
56,583
56,221
56,272
52,336
50,656
53,683
55,280
52,822
50,757

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
21 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
21 May 2025 214.37 220.00
12 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Feb 2025 245.20 225.71
13 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2024 194.20 178.85
27 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Sept 2024 191.40 183.75
27 Mar 2017 CHANGE OF NAME Change Of Name
NA
27 Mar 2017 0.00 0.00

Announcements

Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJun 27, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJun 26, 2025
Closure of Trading WindowJun 25, 2025
DISCLOSURE PURSUANT TO REGULATIONS 30 And 51 OF SEBI (LODR) REGULATIONS 2015: COMPANYS NARODA UNIT SUCCESSFULLY COMPLETED THE UNITED STATES FOOD AND DRUG ADMINISTRATION (US FDA) INSPECTIONJun 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 14, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 06, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 28, 2025
Announcement under Regulation 30 (LODR)-DemiseMay 27, 2025
NEWS PAPER ADVERTISEMENT - Postal Ballot Notice And E-Voting InstructionsMay 26, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotMay 23, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 22, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 22, 2025
Appointment Of Secretarial AuditorMay 21, 2025
Board Meeting Outcome for OUTCOME OF BOARD MEETING ALONGWITH AUDITED FINANCIAL RESULTS ALONGWITH STATUTORY AUDITORS AUDIT REPORT (STANDALONE AND CONSOLIDATED) FOR THE QUARTER AND YEAR ENDED 31/03/2025May 21, 2025
OUTCOME OF BOARD MEETING ALONGWITH AUDITED FINANCIAL RESULTS ALONGWITH STATUTORY AUDITORS AUDIT REPORT (STANDALONE AND CONSOLIDATED) FOR THE QUARTER AND YEAR ENDED 31/03/2025May 21, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 19, 2025
Board Meeting Intimation for Considering Take On Record And Approve The Audited Financial Results Of The Company For The Quarter And Year Ended On 31St March 2025May 16, 2025
DISCLOSURE PURSUANT TO REGULATIONS 30 AND 51 OF SEBI (LODR) REGULATIONS 2015 : AMENDMENT IN TERMS RELATED TO FINANCIAL COVENANTS IN RESPECT OF NON-CONVERTIBLE DEBENTURES (Ncds) ISSUED UNDER ISIN INE385W07034May 01, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 21, 2025
Announcement under Regulation 30 (LODR)-Credit RatingApr 16, 2025
DISCLOSURE PURSUANT TO REGULATIONS 30 AND 51 OF SEBI (LODR) REGULATIONS 2015: COMPANYS WHOLLY-OWNED SUBSIDIARY VIZ. CARBOGEN AMCIS (SHANGHAI) CO. LTD. RECEIVED DRUG MANUFACTURING LICENSE FROM THE NATIONAL MEDICAL PRODUCT ADMINISTRATION FOR ITS SHANGHAI SIApr 09, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateApr 01, 2025
Board Meeting Outcome for OUTCOME OF BOARD MEETING: CESSATION AND APPOINTMENT OF INDEPENDENT DIRECTORSApr 01, 2025
Announcement under Regulation 30 (LODR)-AllotmentMar 26, 2025
PRESS RELEASE REGARDING COMPANYS WHOLLY-OWNED SUBSIDIARY VIZ. CARBOGEN AMCIS SAS. RECEIVED CERTIFICATE OF GMP COMPLIANCE FROM NATIONAL AGENCY FOR THE SAFETY OF MEDICINE AND HEALTH PRODUCTS FOR ITS SAINT-BEAUZIRE SITE FRANCEMar 24, 2025
DISCLOSURE PURSUANT TO REGULATIONS 30 AND 51 OF SEBI (LODR) REGULATIONS 2015: COMPANYS WHOLLY-OWNED SUBSIDIARY VIZ. CARBOGEN AMCIS SAS. RECEIVED CERTIFICATE OF GMP COMPLIANCE FROM NATIONAL AGENCY FOR THE SAFETY OF MEDICINE AND HEALTH PRODUCTS FOR ITS SAINMar 19, 2025
Closure of Trading WindowMar 19, 2025
Board Meeting Outcome for BOARD APPROVES ISSUE OF RATED LISTED SENIOR SECURED REDEEMABLE TAXABLE NON-CONVERTIBLE DEBENTURES AGGREGATING UP TO RS. 50 CRORESMar 12, 2025
Board Meeting Intimation for Consideration And Approval Of The Proposal Of Fund Raising By Way Of Issuance Of Non-Convertible Debentures By Way Of Private Placement Subject To Such Regulatory Or Statutory Approvals As May Be RequiredMar 07, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 13, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 12, 2025
Integrated Filing (Financial)Feb 12, 2025
Board Meeting Outcome for UN-AUDITED FINANCIAL RESULTS AND STATUTORY AUDITORS LIMITED REVIEW REPORT FOR THE THIRD QUARTER ENDED 31/12/2024Feb 12, 2025
UN-AUDITED FINANCIAL RESULTS AND STATUTORY AUDITORS LIMITED REVIEW REPORT FOR THE THIRD QUARTER ENDED 31/12/2024Feb 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 10, 2025
Board Meeting Intimation for Considering Take On Record And Approve The Un-Audited Financial Results Of The Company For The Third Quarter Ended On 31St December 2024Feb 08, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotFeb 04, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 03, 2025
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationJan 31, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJan 31, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJan 10, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 10, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 07, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotDec 31, 2024
Announcement under Regulation 30 (LODR)-CessationDec 14, 2024
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 20, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementNov 19, 2024

Technical Indicators

RSI(14)
Neutral
60.23
ATR(14)
Volatile
10.52
STOCH(9,6)
Neutral
78.40
STOCH RSI(14)
Overbought
84.42
MACD(12,26)
Bullish
0.08
ADX(14)
Strong Trend
27.57
UO(9)
Bearish
54.78
ROC(12)
Uptrend And Accelerating
10.42
WillR(14)
Overbought
-16.17

Mutual Fund Holdings